Register to join us for our webinar on September 19th @ 4pm BST!

With over 12 different types of human papilloma virus (HPV) that can cause cancer, it is the leading cause of cervical cancer in women. The HPV/Pap smear co-test has improved the accuracy of cervical cancer screening; however the test has several limitations. Recent advancements in molecular diagnostics have led to the development of genotype-specific HPV tests that accurately detect and differentiate HPV strains, including high-risk oncogenic types such as HPV-16 and HPV-18.

In this webinar you will:

• Learn about HPV type-specific testing
• Explore the recent trends in HPV diagnostics
• Discover urine-specific genotyping chemistry, which can provide a non-invasive, sensitive method for HPV detection

Date/Time: Thu, Sep 19, 2024 11:00 AM – 12:00 PM EDT

Speaker: Steve Hawkins, Ph.D., Meridian Life Science Molecular Product Manager